Breadcrumb Home Insights Publications article Cost-effectiveness model of long-acting risperidone in schizophrenia in the US Edwards NC, Rupnow MFT, Pashos CL, Botteman MF, Diamond RJ Article Pharmacoeconomics — 23 (3): 299-314